Skip to main content
. Author manuscript; available in PMC: 2007 Apr 20.
Published in final edited form as: J Cereb Blood Flow Metab. 2006 Apr 5;26(12):1538–1550. doi: 10.1038/sj.jcbfm.9600308

Figure 1.

Figure 1

Allocation of animals according to study group. Study animals (n = 141) received one schedule of intranasal tolerization with E-selectin or PBS. Delayed-type hypersensitivity studies were performed assess antibody generation (n = 21) or efficacy of E-selectin doses (n = 98). The other animals (n = 22) were treated on a second tolerization schedule and used for the microarray studies.

HHS Vulnerability Disclosure